Dahlberg, Audun Olav
Aase, Audun
Reiso, Harald
Thortveit, Erik
Eikeland, Randi
Engstrøm, Morten
Midgard, Rune
Funding for this research was provided by:
The Norwegian Multiregional Health Authorities through the BorrSci project.
The Liaison Committee between the Central Norway Regional Health Authority and the Norwegian University of Science and Technology.
Article History
Received: 8 November 2024
Accepted: 12 May 2025
First Online: 16 May 2025
Declarations
:
: The study was approved by the Regional Committee for Medical and Health Research Ethics in South-East Norway (Reference number REK 2018/759 and REK 2013/2082). Informed consent was obtained from all participants, and the participants could withdraw their consent at any time. The study was carried out according to the Declaration of Helsinki.
: Not applicable.
: RE received reimbursement of travel costs and lecture honorarium from Pfizer. The other authors declare that they have no competing interests.
: Not applicable.